Skip navigation
  • Sciety Labs 🧪 (Experimental)
  • Search
Sciety application utilities

Microbiology

  • Subscribe to feed (RSS)

Showing page 130 of 252 pages of list content

  • RNase III-mediated processing of a trans -acting bacterial sRNA and its cis -encoded antagonist

    This article's authors
    1. Sarah L. Svensson
    2. Cynthia M. Sharma
    This article has 9 evaluations Latest evaluation on Dec 6, 2021 Published on Nov 15, 2021
  • Antiviral activity of Molnupiravir precursor NHC against SARS-CoV-2 Variants of Concern (VOCs) and implications for the therapeutic window and resistance

    This article's authors
    1. Tessa Prince
    2. I’ah Donovan-Banfield
    3. Hannah Goldswain
    4. Rebekah Penrice-Randal
    5. Catherine Hartley
    6. Saye Khoo
    7. Tom Fletcher
    8. Julian A. Hiscox
    This article has 1 evaluations Latest evaluation on Nov 30, 2021 Published on Feb 2, 2023
  • SARS-CoV-2 spike protein as a bacterial lipopolysaccharide delivery system in an overzealous inflammatory cascade

    This article's authors
    1. Firdaus Samsudin
    2. Palur Raghuvamsi
    3. Ganna Petruk
    4. Manoj Puthia
    5. Jitka Petrlova
    6. Paul MacAry
    7. Ganesh S. Anand
    8. Artur Schmidtchen
    9. Peter J. Bond
    This article has 4 evaluations Latest evaluation on Feb 14, 2022 Published on Nov 6, 2021
  • Glycan-masking spike antigen in NTD and RBD elicits broadly neutralizing antibodies against SARS-CoV-2 variants

    This article's authors
    1. Wei-Shuo Lin
    2. I-Chen Chen
    3. Hui-Chen Chen
    4. Yi-Chien Lee
    5. Suh-Chin Wu
    This article has 1 evaluations Latest evaluation on Nov 19, 2021 Published on Nov 2, 2021
  • Inactivation of SARS Coronavirus 2 and COVID-19 patient samples for contemporary immunology and metabolomics studies

    This article's authors
    1. Devon J. Eddins
    2. Leda Bassit
    3. Joshua D. Chandler
    4. Natalie S. Haddad
    5. Katie L. Musall
    6. Junkai Yang
    7. Astrid Kosters
    8. Brian S. Dobosh
    9. Mindy R. Hernández
    10. Richard P. Ramonell
    11. Rabindra M. Tirouvanziam
    12. F. Eun-Hyung Lee
    13. Keivan Zandi
    14. Raymond F. Schinazi
    15. Eliver E.B. Ghosn
    This article has 1 evaluations Latest evaluation on Nov 19, 2021 Published on Oct 24, 2021
  • Microglia do not restrict SARS-CoV-2 replication following infection of the central nervous system of K18-hACE2 transgenic mice

    This article's authors
    1. Gema M. Olivarria
    2. Yuting Cheng
    3. Susana Furman
    4. Collin Pachow
    5. Lindsay A. Hohsfield
    6. Charlene Smith-Geater
    7. Ricardo Miramontes
    8. Jie Wu
    9. Mara S. Burns
    10. Kate I. Tsourmas
    11. Jennifer Stocksdale
    12. Cynthia Manlapaz
    13. William H. Yong
    14. John Teijaro
    15. Robert Edwards
    16. Kim N. Green
    17. Leslie M. Thompson
    18. Thomas E. Lane
    This article has 1 evaluations Latest evaluation on Nov 20, 2021 Published on Nov 17, 2021
  • A biosafety level 2 surrogate for studying SARS-CoV-2 survival in food processing environmental biofilms

    This article's authors
    1. Austin B. Featherstone
    2. Sapna Chitlapilly Dass
    This article has 1 evaluations Latest evaluation on Nov 19, 2021 Published on Nov 1, 2021
  • SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity

    This article's authors
    1. Sabari Nath Neerukonda
    2. Russell Vassell
    3. Sabrina Lusvarghi
    4. Richard Wang
    5. Fernando Echegaray
    6. Lisa Bentley
    7. Ann E. Eakin
    8. Karl J. Erlandson
    9. Leah C. Katzelnick
    10. Carol D. Weiss
    11. Wei Wang
    This article has 1 evaluations Latest evaluation on Nov 19, 2021 Published on Nov 8, 2021
  • Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant

    This article's authors
    1. Natasha N. Gaudreault
    2. Konner Cool
    3. Jessie D. Trujillo
    4. Igor Morozov
    5. David A. Meekins
    6. Chester McDowell
    7. Dashzeveg Bold
    8. Mariano Carossino
    9. Velmurugan Balaraman
    10. Dana Mitzel
    11. Taeyong Kwon
    12. Daniel W. Madden
    13. Bianca Libanori Artiaga
    14. Roman M. Pogranichniy
    15. Gleyder Roman-Sosa
    16. William C. Wilson
    17. Udeni B. R. Balasuriya
    18. Adolfo García-Sastre
    19. Juergen A. Richt
    This article has 1 evaluations Latest evaluation on Nov 20, 2021 Published on Nov 22, 2021
  • Serum from COVID-19 patients early in the pandemic shows limited evidence of cross-neutralization against variants of concern

    This article's authors
    1. Amanda J. Griffin
    2. Kyle L. O’Donnell
    3. Kyle Shifflett
    4. John-Paul Lavik
    5. Patrick M. Russell
    6. Michelle K. Zimmerman
    7. Ryan F. Relich
    8. Andrea Marzi
    This article has 1 evaluations Latest evaluation on Nov 19, 2021 Published on Nov 12, 2021
Previous Next
Stay updated. Get involved.
Subscribe to Mailing List
  • Blog
  • About Sciety
  • Contact
  • Follow us on Twitter
  • Follow us on Facebook
© 2022 eLife Sciences Publications Ltd. Legal information